Gallery

Life Triumphs Over Rare Blood Cancer: 32-Year-Old Defeats High-Risk APML, Inspires Hope

A 32-year-old female was diagnosed with high-risk APML, a rare type of blood cancer that, if left untreated, can lead to death. Early diagnosis and prompt management are crucial for saving lives. Successfully treating a deadly cancer like high-risk APML brings a sense of contentment for any oncologist, as relapse rates for this blood cancer are rare once cured

Life Triumphs Over Rare Blood Cancer: 32-Year-Old Defeats High-Risk APML, Inspires Hope

A 32-year-old female was diagnosed with high-risk APML, a rare type of blood cancer that, if left untreated, can lead to death. Early diagnosis and prompt management are crucial for saving lives. Successfully treating a deadly cancer like high-risk APML brings a sense of contentment for any oncologist, as relapse rates for this blood cancer are rare once cured

Successful Treatment of Mixed Phenotype Leukemia in a Young Boy

A 4-year-old boy presented with nosebleeds and fever. Upon examination, his platelet count was low, and his white blood cell count was high. A bone marrow examination revealed mixed phenotype leukemia, a rare form of blood cancer with two variants: Acute lymphoblastic leukemia and Acute Myeloid leukemia. He underwent one month of induction chemotherapy. Following treatment, a bone marrow reevaluation showed morphological and molecular remission of both cancers, and he has remained disease-free for the past three years

Breakthrough in Cancer Treatment: Immune Checkpoint Inhibitor Therapy Shows Remarkable Results in Stage 4 Head and Neck Cancer Patient

The 65-year-old businessman has been diagnosed with stage 4 head and neck cancer, and unfortunately, standard chemotherapy and radiation treatments were ineffective. His disease progressed rapidly, leading to the development of cancer deposits on his skin (skin metastases). Historically, patients with skin metastases would often succumb to the disease as previous treatments failed to yield results. However, with the introduction of the latest immune checkpoint inhibitor therapy, there has been a remarkable complete response in his disease. The recent advancements in medical oncology demonstrate the potential for transformative outcomes.

Triumph Over Stage 4 Breast Cancer: Woman Defies Odds with Remarkable Recovery

A vibrant 62-year-old woman sought evaluation due to weight loss and a concerning lump in her breast, only to be diagnosed with stage 4 breast cancer. PET-CT imaging revealed a staggering ninety percent of her liver overrun by the disease. Undeterred, she bravely faced chemotherapy and targeted therapy. Miraculously, a re-evaluation scan unveiled a complete vanquishing of both her primary ailment and liver metastases

Unveiling Paraneoplastic Skin Manifestations: Woman’s Thymoma Diagnosis Leads to Remarkable Skin Lesion Recovery

A 64-year-old woman experienced severe, painful skin lesions on her face, trunk, and legs. Despite seeking treatment from a dermatologist, she found no relief. Upon further evaluation, she was diagnosed with Thymoma. Interestingly, these skin lesions were not caused by the physical presence of cancerous tissue in the skin but rather by a paraneoplastic manifestation. Treating the underlying cancer proved to be the most effective solution. As the cancer responded to chemotherapy, so did the skin lesions, showing an excellent response

Young Cricket Lover Beats Brain Tumor: Achieves Complete Radiological Response with Chemotherapy

A 12-year-old cricket enthusiast experienced a sudden onset of double vision. Upon evaluation, he was diagnosed with a brain tumor known as “Germ Cell Tumor.” Chemotherapy led to a complete radiological response, as depicted in the image. Subsequently, he underwent radiation therapy as part of consolidation treatment to prevent disease recurrence

First Medical Oncologist In South India to give targeted therapy called “Polatuzumab Vedotin” in first line for Non Hodgkin Lymphoma

Stage IV Lung Cancer Patients showing complete response with Chemotherapy/Targeted Therapy/Immunotherapy
One of the first Medical Oncologist in Hyderabad to give Subcutaneous monclonal antibody called Phesgo used for breast cancer in June 2022
Dr Udaykumar Punukollu delivering a speech after receiving ” Best All Rounder Oncologist In India” Award for the year 2022 by National Oncologists platform -Indian Co-Operative Oncology Network (ICON)

Get Expert Consultation from Dr. Udaykumar Punukollu